17 matches for your search in the start-up spotlight
rss
Noscendo GmbH is the leading global provider of software-based pathogen identification technology. We’ve made it our objective to revolutionise infection diagnostics, thus saving patient lives. Scores of well-known university hospitals, major regional hospitals and hospital groups are already ...
Founded in 2017, in Eindhoven, The Netherlands, Onera Health is a spin-off of imec research center, a leader in nanoelectronics and digital technologies. Our mission is to make clinical-grade remote diagnostics and monitoring broadly accessible and user-friendly to anyone who needs it, wherever ...
To detect hereditary diseases and genetic defects, physicians as well as researchers need appropriate tools. It is also essential to have the appropriate tools to support law enforcement agencies in resolving crimes and facilitating other legal issues, like kinship and paternity cases. Overtime ...
The SeNostic Health GmbH is a diagnostics start-up company founded in 2017 and located at Hannover's Medical Park, Germany. SeNostic develops its proprietary SeedCycler® technology platform for the precise and accurate early differential diagnosis of neurodegenerative disorders, including ...
Founded in 2017, NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura” for short) is committed to building an global leading RNA innovative drug platform. It has built multi-omics big data collection platform and multi-biomics database to perform in-dcpth drug target mining and fully automated ...
At Mammoth, we discover novel CRISPR systems that enable new possibilities for expanding biology. Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential ...
Elypta is developing the first-ever metabolism-based liquid biopsy platform for early detection and closer follow-up of multiple cancer indications. The platform is inherently safe and convenient, exceptionally sensitive in studies to date and the low cost assay technology allows for broad use. ...
Ares Genetics - an OpGen Group Company - is developing DNA-based infectious disease services and solutions for drug response prediction to improve the way antimicrobial resistant (AMR) infections are diagnosed, and prevented or treated. Our innovative AI-powered and Machine Learning (ML) driven ...
We provide reliable rapid tests for the on-site detection of specific genes in a variety of microorganisms. Because of the increasing demand for quick and dependable results for the diagnosis of infectious diseases, we have developed a novel molecular detection method. Due to our extensive work ...
Biological equilibria and metabolic processes, from bacterial fermentation to human health, fascinating and complex at the same time, form the basis of our daily work. Using state-of-the-art analyses based on nuclear magnetic resonance technology, we record hundreds of metabolic products. Our ...
